| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 4,512 | 3,625 | ||
| Marketable securities | 48,628 | 73,607 | ||
| Total current assets | 53,140 | 77,232 | ||
| Total assets | 53,140 | 77,232 | ||
| Convertible notes payable related party net of debt discount-Notes Payable One | - | 525,000 | ||
| Accounts payable and accrued expenses | 959,797 | 778,478 | ||
| Accounts expenses related party-Related Party | 938,774 | 1,026,649 | ||
| Convertible notes payable related party net of debt discount-Notes Payable Two | - | 173,192 | ||
| Accounts payable - related party-Related Party | 911,659 | 911,659 | ||
| Short -term advances - related party-Related Party | 1,815,858 | 1,779,058 | ||
| Convertible note payable - net of debt discount-Related Party | 173,192 | - | ||
| Derivative liability | 3,297,695 | - | ||
| Convertible note payable - net of debt discount-Nonrelated Party | 525,000 | - | ||
| Notes payable - related party-Related Party | 106,850 | 106,850 | ||
| Total current liabilities | 8,728,825 | 5,300,886 | ||
| Total liabilities | 8,728,825 | 5,300,886 | ||
| Common stock, 0.0001 par value authorized 500,000,000, 22,454,264 and 21,674,000 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively | 2,245 | 2,167 | ||
| Additional paid-in capital | 952,603 | 810,048 | ||
| Accumulated deficit | -9,630,533 | -6,035,869 | ||
| Total stockholders deficit | -8,675,685 | -5,223,654 | ||
| Total liabilities and stockholders deficit | 53,140 | 77,232 | ||
Balance Labs, Inc. (BLNC)
Balance Labs, Inc. (BLNC)